
Join to view full profile
3130 Highland AveCincinnati, OH 45219
Phone+1 513-584-4268
Fax+1 513-584-6955
Dr. Curran is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ChicagoFellowship, Hematology and Medical Oncology, 2012 - 2015
University of ChicagoResidency, Internal Medicine, 2008 - 2011
Stanford University School of MedicineClass of 2008
Certifications & Licensure
OH State Medical License 2019 - 2027
IL State Medical License 2011 - 2020
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Signaling Mutations Negate the Favorable Impact of NPM1 Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With VEN/HMA.Fieke W Hoff, Joshua F Zeidner, Geeta Torlapati, Deedra Nicolet, Krzysztof Mrózek
American Journal of Hematology. 2026-09-01 - Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model.Curtis A Lachowiez, Joshua F Zeidner, Jad Othman, Andy Kaempf, Seongseok Yun
Journal of Clinical Oncology. 2026-09-01 - Adolescents and Young Adults With Acute Lymphoblastic Leukemia: Qualitative Barriers and Facilitators to Guideline-Concordant Care.Allison C Grimes, Julie A Wolfson, Charlotte L Kerber, Kristin M Bingen, Melissa P Beauchemin
Cancer Control. 2026-07-20
Abstracts/Posters
- Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with Inotuzumab OzogamicinEmily K Curran, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Real World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated with BlinatumomabEmily K Curran, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Press Mentions
Blood Cancer Healing Center Marks First Anniversary with Holistic Care ApproachJuly 28th, 2025
Multi-Institutional Team Awarded NCI Grant to Open Novel AML TrialJune 23rd, 2025
Ponatinib and Blinatumomab Combination Safe and Effective in Patients with Newly Diagnosed, Ph-Positive ALLFebruary 3rd, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: